1. Home
  2. BDSX vs LARK Comparison

BDSX vs LARK Comparison

Compare BDSX & LARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • LARK
  • Stock Information
  • Founded
  • BDSX 2005
  • LARK 1885
  • Country
  • BDSX United States
  • LARK United States
  • Employees
  • BDSX N/A
  • LARK N/A
  • Industry
  • BDSX Precision Instruments
  • LARK Major Banks
  • Sector
  • BDSX Health Care
  • LARK Finance
  • Exchange
  • BDSX Nasdaq
  • LARK Nasdaq
  • Market Cap
  • BDSX 115.4M
  • LARK 167.5M
  • IPO Year
  • BDSX 2020
  • LARK N/A
  • Fundamental
  • Price
  • BDSX $0.35
  • LARK $28.81
  • Analyst Decision
  • BDSX Strong Buy
  • LARK
  • Analyst Count
  • BDSX 4
  • LARK 0
  • Target Price
  • BDSX $2.83
  • LARK N/A
  • AVG Volume (30 Days)
  • BDSX 523.2K
  • LARK 31.0K
  • Earning Date
  • BDSX 05-13-2025
  • LARK 04-30-2025
  • Dividend Yield
  • BDSX N/A
  • LARK 2.96%
  • EPS Growth
  • BDSX N/A
  • LARK 27.69
  • EPS
  • BDSX N/A
  • LARK 2.59
  • Revenue
  • BDSX $71,323,000.00
  • LARK $60,798,000.00
  • Revenue This Year
  • BDSX $32.90
  • LARK N/A
  • Revenue Next Year
  • BDSX $24.65
  • LARK N/A
  • P/E Ratio
  • BDSX N/A
  • LARK $11.20
  • Revenue Growth
  • BDSX 45.30
  • LARK 9.30
  • 52 Week Low
  • BDSX $0.45
  • LARK $17.53
  • 52 Week High
  • BDSX $2.04
  • LARK $31.04
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 27.69
  • LARK 52.68
  • Support Level
  • BDSX $0.51
  • LARK $28.50
  • Resistance Level
  • BDSX $0.58
  • LARK $31.00
  • Average True Range (ATR)
  • BDSX 0.06
  • LARK 1.21
  • MACD
  • BDSX -0.01
  • LARK -0.15
  • Stochastic Oscillator
  • BDSX 1.15
  • LARK 39.89

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

Share on Social Networks: